JMP keeps Stryker at market perform

Stryker Corp. was maintained by JMP Securities analyst Robert Faulkner at a market perform rating. The Stryker quarter was relatively uneventful. Revenues were $1.279 million versus JMP's estimate of $1.290 million, while earnings per share were in line with the analyst's estimate at $0.48. Shares of the Kalamazoo, Mich., medical products company were up $6.00, or 13.53%, at $50.33 on volume of 6,956,000 shares versus the three-month running average of 1,847,990 shares. (NYSE: SYK)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.